Press Releases
-
Rho Ranks First for Extra-Large Company by Triangle Business Journal Best Places to Work
CHAPEL HILL, NC - Sep 11, 2018 - For Immediate releaseRho Ranks First for Extra-Large Company byTriangle Business Journal Best Places to WorkCRO recognized for its company culture and flexible work environmentChapel Hill, NC - September 11, 2018 - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, announced today that the Triangle Business Journal has ranked the company as the number one extra-large company
Sep 11, 2018
-
PAREXEL Advances Patient-Centric Drug Development with Introduction of its Patient Innovation Center
LINCOLN, UNITED KINGDOM - Sep 11, 2018 - BOSTON, September 11, 2018 - PAREXEL International Corporation, a leading innovator of global biopharmaceutical services, today announced the launch of its Patient Innovation Center, designed to help guide sponsors in their efforts to improve efficiency and success across all areas of biopharmaceutical development including clinical trial design, recruitment, execution and market access
Sep 11, 2018
-
BioIVT Publishes New Research On the Mechanisms Underlying the C-DILI Assay
WESTBURY, NY, US - Sep 10, 2018 - BioIVT, a leading provider of research models and services for drug development, today announced its research into the mechanisms involved in cholestatic drug-induced liver injury (DILI) has been published in Applied In Vitro Toxicology
Sep 10, 2018
-
BioIVT Launches Dissociated Tumor Cell (DTC) Product Line to Advance Oncology Research
WESTBURY, NY, US - Sep 6, 2018 - BioIVT, a leading provider of research models and services for drug development, today announced the addition of a dissociated tumor cell (DTC) product line to its immunology portfolio
Sep 6, 2018
-
Certara Appoints Dr. Mark Holbrook to Lead Its Quantitative Systems Toxicology and Safety Division
PRINCETON, NJ, US - Sep 5, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, today announced that it has appointed Mark Holbrook, PhD, to the newly-created position of vice president of quantitative systems toxicology and safety (QSTS)
Sep 5, 2018
-
CRF Health Partners Innovative US Biotech with TrialMax® eCOA Solution for Phase III Prostate Oncology Study
PLYMOUTH MEETING, PA - Aug 30, 2018 - CRF Health, the leading provider of patient-centered eSource technology solutions for the life sciences industry, today announced that its TrialMax® Slate solution has been selected by a US biotech company for a global Phase III prostate cancer study
Aug 30, 2018
-
Greenphire Named to Inc. 5000 List for Sixth Consecutive Year
KING OF PRUSSIA, PA - Aug 29, 2018 - Greenphire, the global leader in financial software for clinical trials, today announced that it has been named to the 2018 Inc
Aug 29, 2018
-
The Pistoia Alliance Announces Number of Reactions in its Chemical Safety Library Service has Increased Four-Fold
BOSTON, MA - Aug 23, 2018 - The Pistoia Alliance, a global, not for profit alliance that works to lower barriers to innovation in life sciences R&D, is today announcing a number of milestones in its Chemical Safety Library (CSL) Service project, launched in March 2017
Aug 22, 2018
-
ERT Appoints Industry Veteran to Advance eCOA Strategy
PHILADELPHIA, PA, UNITED STATES - Aug 20, 2018 - ERT, a global data and technology company that minimizes uncertainty and risk in clinical trials, today announced the appointment of Zaher El-Assi as Executive Vice President and Product Line Executive for electronic Clinical Outcome Assessments (eCOA)
Aug 20, 2018
-
CRF Health Launches Self-Service Model for TrialConsent® Platform
PLYMOUTH MEETING, PA - Aug 20, 2018 - CRF Health, the leading global provider of patient-centered eSource technology and service solutions for the life sciences industry, launches a self-service capability and a customer enablement program to empower CROs and Sponsors to manage all aspects of electronic informed consent using a licensed, cloud-based version of the industrys first electronic informed consent platform with fully embedded design tool
Aug 20, 2018
-
Certara’s D360 Version 10.5 Extends Platform’s Ability to Optimize Discovery Research Across Therapeutic Modalities
PRINCETON, NJ - Aug 15, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, today announced the launch of D360 v10
Aug 15, 2018
-
ActiveRADAR Expands Leadership Team to Support Industry Demand, Company Momentum
SACRAMENTO, CA, UNITED STATES - Aug 14, 2018 - ActiveRADAR (formerly known as RxTE Health), a company specializing in pharmacy cost reduction programs for employers, today announced the addition of three healthcare executives to its leadership team
Aug 14, 2018
-
TULA Recognized As The 10 Most Trusted Risk and Compliance Solution Providers
NEW JERSEY, NJ - Aug 14, 2018 - Now a days, the risk and compliance solutions are empowering companies to create and coordinate, to control and map solutions to regulatory & internal compliance requirement as well
Aug 14, 2018
-
ALBUMEDIX ANNOUNCES EVALUATION AGREEMENT WITH A TOP PHARMA COLLABORATOR
NNOTTINGHAM, UNITED KINGDOM - Aug 1, 2018 - Nottingham, UK, August 1st – Novartis and Albumedix Ltd. (Albumedix) have entered into an agreement to evaluate the development of several first-in-class therapeutics using Albumedixs Veltis® technology platform and associated technologies
Aug 1, 2018
-
Certara Experts Highlight Quantitative Systems Pharmacology’s Role in First-in-Human Clinical Trials
PRINCETON, NJ - Jul 26, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence services, announced today that Clinical Pharmacology & Therapeutics has published its Letter to the Editor describing the important role that quantitative systems pharmacology (QSP) can play in defining dosing criteria for first-in-human (FIH) clinical trials,1 together with the European Medicines Agencys (EMAs) response
Jul 26, 2018
-
Almac Clinical Technologies Releases New Podcast Series Entitled “Spotlight on IRT: Best Practices”
SOUDERTON, PA - Jul 25, 2018 - Almac Clinical Technologies, a global leader in technology-enabled solutions for managing clinical trial patient and supplies data through its flagship IXRS® 3 Interactive Response Technology (IRT) debuts a first-in-industry podcast series entitled, Spotlight on IRT: Best Practices
Jul 25, 2018
-
The Pistoia Alliance Launches the 2018 President’s Startup Challenge
- Jul 24, 2018 - The Pistoia Alliance has announced today that entries for its 2018 Presidents Startup Challenge are now open, and will close on Monday, 3rd September 2018
Jul 24, 2018
-
Genstar Capital to Acquire CRF Health from Vitruvian Partners and Combine with Bracket
, PA - Jul 17, 2018 - London, United Kingdom and Wayne, Pennsylvania, USA - Genstar Capital, a leading investor in healthcare technology and services companies, is pleased to announce the acquisition of CRF Health, a global provider of eCOA and eConsent solutions for the life sciences industry
Jul 17, 2018
-
Rho Offers Tips for Cellular Therapy Studies
CHAPEL HILL, NC - Jul 17, 2018 - For Immediate Release Rho Offers Tips for Cellular Therapy StudiesCRO shares challenges for cellular therapy in clinical trials Chapel Hill, NC ̶ July 16, 2018 Rho, a contract research organization (CRO) focused on bringing new products to market through a full range of product development services, offers tips on overcoming the challenges associated with cellular therapy clinical trials
Jul 16, 2018
-
MR Solutions installs Hawaii’s first preclinical MRI imaging system
GUILDFORD, UNITED KINGDOM - Jul 16, 2018 - MR Solutions has installed Hawaiis first preclinical cryogen-free MRI imaging system to help researchers improve the rate of kidney disease detection through research
Jul 16, 2018
